Loading clinical trials...
Loading clinical trials...
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer: Feasibility and Preliminary Efficacy of a Tailored, eHealth Supportive Oncology Intervention
The purpose of this study is to develop and tailor an intervention program to improve the quality of life in women living with metastatic breast cancer. In the first phase of this study, we conducted patient focus groups to gather information about the unique challenges of living with MBC and what kinds of support women would like to receive in a tailored Acceptance and Commitment Therapy (ACT) intervention. In the second phase of the study, we will conduct a three-arm randomized controlled trial to the tailored ACT intervention with both a Cognitive Behavioral Stress Management (CBSM) intervention and usual care. The CBSM and ACT intervention groups will meet with a trained facilitator and 8-9 other patients, once per week via videoconference for 90 minute sessions over the course of 8 weeks.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Start Date
April 24, 2019
Primary Completion Date
March 8, 2021
Completion Date
March 8, 2021
Last Updated
September 2, 2021
31
ACTUAL participants
Acceptance and Commitment Therapy (ACT)
BEHAVIORAL
Cognitive Behavioral Stress Management (CBSM)
BEHAVIORAL
Lead Sponsor
Northwestern University
Collaborators
NCT06625775
NCT06649331
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions